[go: up one dir, main page]

FR2407000A1 - - Google Patents

Info

Publication number
FR2407000A1
FR2407000A1 FR7830517A FR7830517A FR2407000A1 FR 2407000 A1 FR2407000 A1 FR 2407000A1 FR 7830517 A FR7830517 A FR 7830517A FR 7830517 A FR7830517 A FR 7830517A FR 2407000 A1 FR2407000 A1 FR 2407000A1
Authority
FR
France
Prior art keywords
influenzae type
phosphate
ribosyl
ribitol
children
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7830517A
Other languages
French (fr)
Other versions
FR2407000B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/846,466 external-priority patent/US4196192A/en
Priority claimed from US05/846,488 external-priority patent/US4220717A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FR2407000A1 publication Critical patent/FR2407000A1/fr
Application granted granted Critical
Publication of FR2407000B1 publication Critical patent/FR2407000B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ON PREPARE UN VACCIN COMBINE CONTENANT DU POLY-RIBOSYL-RIBITOL-PHOSPHATE ISOLE DE CULTURE D'H. INFLUENZAE DE TYPE B ET PURIFIE SELON UN NOUVEAU PROCEDE UTILISANT UN ABSORBANT PHOSPHATE ET DES ANTIGENES DE B. PERTUSSIS. L'INVENTION S'APPLIQUE EN PARTICULIER A L'IMMUNISATION TRES ACTIVE (VOIR FIGURE) DES ENFANTS ET DES JEUNES ANIMAUX A SANG CHAUD CONTRE LES INFECTIONS PROVOQUEES PAR H. INFLUENZAE TYPE B.A COMBINATION VACCINE CONTAINING POLY-RIBOSYL-RIBITOL-PHOSPHATE ISOLATED FROM CULTURE OF H. IS PREPARED. INFLUENZAE TYPE B AND PURIFIED ACCORDING TO A NEW PROCESS USING A PHOSPHATE ABSORBENT AND B. PERTUSSIS ANTIGENS. THE INVENTION APPLIES IN PARTICULARLY TO VERY ACTIVE IMMUNIZATION (SEE FIGURE) OF CHILDREN AND YOUNG ANIMALS WITH HOT BLOOD AGAINST INFECTIONS CAUSED BY H. INFLUENZAE TYPE B.

FR7830517A 1977-10-28 1978-10-26 Expired FR2407000B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/846,466 US4196192A (en) 1977-10-28 1977-10-28 Combined Haemophilus influenzae type b and pertussis vaccine
US05/846,488 US4220717A (en) 1977-12-22 1977-12-22 Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.

Publications (2)

Publication Number Publication Date
FR2407000A1 true FR2407000A1 (en) 1979-05-25
FR2407000B1 FR2407000B1 (en) 1983-01-21

Family

ID=27126641

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7830517A Expired FR2407000B1 (en) 1977-10-28 1978-10-26

Country Status (25)

Country Link
JP (1) JPS5480408A (en)
AR (1) AR218932A1 (en)
AU (1) AU520902B2 (en)
BE (1) BE871586A (en)
CA (1) CA1117866A (en)
CH (1) CH649781A5 (en)
DD (1) DD140701A5 (en)
DE (1) DE2845745A1 (en)
DK (1) DK154327C (en)
ES (1) ES474611A1 (en)
FI (1) FI63674C (en)
FR (1) FR2407000B1 (en)
GB (1) GB2007244B (en)
GR (1) GR73991B (en)
HU (1) HU178166B (en)
IE (1) IE47474B1 (en)
IL (1) IL55433A (en)
IT (1) IT1107570B (en)
NL (1) NL7810753A (en)
NO (1) NO149611C (en)
NZ (1) NZ188211A (en)
PH (1) PH15882A (en)
PL (1) PL210545A1 (en)
SE (1) SE430753B (en)
YU (1) YU250878A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072513A3 (en) * 1981-08-14 1986-02-19 Smith Kline - Rit Societe Anonyme Dite: Process for the preparation of purified bacterial capsular antigenic polysaccharides, the obtained products and their use
EP0101562A3 (en) * 1982-08-20 1986-04-09 American Cyanamid Company Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
EP0528635A1 (en) * 1991-08-16 1993-02-24 Merck & Co. Inc. Process for converting lipid-containing polysaccharide into lipid-free polysaccharide
EP0471177A3 (en) * 1990-08-13 1993-02-24 American Cyanamid Company Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines
RU2121365C1 (en) * 1992-10-27 1998-11-10 Американ Цианамид Компани The mixed vaccine, a method of simultaneous mixed vaccination and a method of immunogenicity increase

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744982A (en) * 1982-08-24 1988-05-17 Hunter Kenneth W Human monoclonal antibody reactive with polyribosylribitol phosphate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2295758A1 (en) * 1974-12-24 1976-07-23 Behringwerke Ag COQUELUCHE PROTECTIVE ANTIGEN, ITS PREPARATION PROCESS AND PRODUCTS CONTAINING THIS ANTIGEN
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
NO116869B (en) * 1965-01-19 1969-06-02 Merck & Co Inc
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
NL174267B (en) * 1969-05-20 Roussel Uclaf IMPROVEMENT OF THE PROCESS FOR THE PREPARATION OF A SOMATIC ANTIGEN ACCORDING TO DUTCH PATENT 169754 AND PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION.
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines
FR2253499B1 (en) * 1973-12-10 1977-11-04 Fabre Sa Pierre

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2295758A1 (en) * 1974-12-24 1976-07-23 Behringwerke Ag COQUELUCHE PROTECTIVE ANTIGEN, ITS PREPARATION PROCESS AND PRODUCTS CONTAINING THIS ANTIGEN
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1971 *
CA1977 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072513A3 (en) * 1981-08-14 1986-02-19 Smith Kline - Rit Societe Anonyme Dite: Process for the preparation of purified bacterial capsular antigenic polysaccharides, the obtained products and their use
EP0101562A3 (en) * 1982-08-20 1986-04-09 American Cyanamid Company Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
EP0471177A3 (en) * 1990-08-13 1993-02-24 American Cyanamid Company Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines
EP0528635A1 (en) * 1991-08-16 1993-02-24 Merck & Co. Inc. Process for converting lipid-containing polysaccharide into lipid-free polysaccharide
WO1993004183A1 (en) * 1991-08-16 1993-03-04 Merck & Co., Inc. Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide
RU2121365C1 (en) * 1992-10-27 1998-11-10 Американ Цианамид Компани The mixed vaccine, a method of simultaneous mixed vaccination and a method of immunogenicity increase

Also Published As

Publication number Publication date
AU520902B2 (en) 1982-03-04
ES474611A1 (en) 1980-01-16
DE2845745A1 (en) 1979-05-10
IT7851621A0 (en) 1978-10-24
JPS6231694B2 (en) 1987-07-09
SE430753B (en) 1983-12-12
BE871586A (en) 1979-04-27
DE2845745C2 (en) 1987-10-01
GB2007244B (en) 1982-03-31
AU4108178A (en) 1980-05-01
NO783635L (en) 1979-05-02
DK154327C (en) 1989-04-03
JPS5480408A (en) 1979-06-27
AR218932A1 (en) 1980-07-15
GB2007244A (en) 1979-05-16
SE7811192L (en) 1979-04-29
IL55433A (en) 1982-09-30
YU250878A (en) 1983-12-31
IL55433A0 (en) 1978-10-31
DD140701A5 (en) 1980-03-26
FI63674C (en) 1983-08-10
NZ188211A (en) 1984-09-28
FI783269A7 (en) 1979-04-29
PH15882A (en) 1983-04-13
NL7810753A (en) 1979-05-02
DK154327B (en) 1988-11-07
HU178166B (en) 1982-03-28
GR73991B (en) 1984-06-06
FI63674B (en) 1983-04-29
DK479578A (en) 1979-04-29
CH649781A5 (en) 1985-06-14
CA1117866A (en) 1982-02-09
IT1107570B (en) 1985-11-25
IE782146L (en) 1979-04-28
PL210545A1 (en) 1980-02-25
FR2407000B1 (en) 1983-01-21
NO149611C (en) 1984-05-23
IE47474B1 (en) 1984-03-21
NO149611B (en) 1984-02-13

Similar Documents

Publication Publication Date Title
ATE23270T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING IMMUNOGLOBULIN AND FIBRONECTIN.
FI900412A0 (en) ANTIVIRAL ELLER ANTIBAKTERIELL FOERENING OCH FOERFARANDE FOER ANVAENDNING DAERAV.
ATE237351T1 (en) TYPE I SURFACE ANTIGENS ASSOCIATED WITH STAPHYLOCOCCUS EPIDERMIDIS
FI943171A0 (en) Urea-based vaccine against Helicobacter infection
ES2123064T3 (en) USE OF MELATONIN IN SMALL ORAL DOSE AS SOMNIFERO.
ATE4168T1 (en) 2-PHENYL-1,2-BENZISOSELENAZOLE-3(2H)-ONE CONTAINING PHARMACEUTICAL PREPARATIONS AND THEIR USE.
NO821832L (en) PROCEDURE FOR THE PREPARATION OF ALLERGIC Capsules
Harmon et al. Therapy of murine rabies after exposure: efficacy of polyriboinosinic-polyribocytidylic acid alone and in combination with three rabies vaccines
FR2407000A1 (en)
NO872919L (en) PERTUSSIS TOXIN PREPARATION FOR CULTIVATION OF BODELLA PERTUSSIS.
Maibach et al. Bacterial interference: relating to chronic furunculosis in man
LU90378I2 (en) Tetravac
ATE122100T1 (en) HUMAN MONOCLONAL ANTIBODIES AND MEDICINAL COMPOSITION CONTAINING SAME FOR THE TREATMENT OF PSEUDOMONASIC INFECTIONS.
Ravin et al. Hypertrichosis portrayed in art
Weech THE PROPHYLAXIS OF VARICELLA WITH CONVALESCENTS'SERUM
FR2457693A1 (en) TETRAMISOLE AND LEVAMISOLE AS ADJUVANT FOR CLOSTRIDIUM DISEASE VACCINE AND VACCINE CONTAINING SAME
FR2331354A2 (en) ACTIVE IMMUNIZATION AGAINST VIRAL HEPATITIS VACCINE AND PREPARATION METHOD
Hill et al. Recurrent herpes: is reactivation controlled in the skin?
SU651805A1 (en) Method of treating cornea disease
BE882684A (en) PROCESS FOR THE PREPARATION OF AN ANTIRABIC VACCINE AND VACCINE OBTAINED ACCORDING TO THIS PROCESS
ATE111485T1 (en) PEPTIDE TREATMENT OF PERSISTENT INFECTIOUS DISEASES.
GR3021983T3 (en) Cross-reactive influenza a immunization
BRADFORD et al. Effect of refined antipertussis rabbit serum on the humoral antibody titer in pertussis
Smith The modification of scarlatinal toxin by formaldehyde
Enders The Gordon Wilson Lecture. Observations on Certain Viruses Causing Exanthematous Diseases in Man

Legal Events

Date Code Title Description
ST Notification of lapse